RxDoctor Payments Data

Lisa Parker, MD

Family Medicine · Mount Vernon, MONPI 1578682324

Payments from drug & device makers

$949in general payments, 2019–2025

Across 51 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$239
  • KCI USA, Inc.$135
  • Kowa Pharmaceuticals America, Inc.$98
  • AbbVie$81
  • Novo Nordisk$81
  • Otsuka America Pharmaceutical, Inc.$53
  • plus $261 from 10 others

What the payments were for

  • Food & beverage$949100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$949 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$30,947
Medicare patients
89
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide57$74,145
OzempicSemaglutide47$58,974
EliquisApixaban39$31,754
JardianceEmpagliflozin17$19,228
JanuviaSitagliptin Phosphate15$15,447
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,539
FarxigaDapagliflozin Propanediol18$12,510
XareltoRivaroxaban12$10,903
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$7,524
MyrbetriqMirabegron11$4,763
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen162$2,768
Duloxetine Hcl92$1,889
LantusInsulin Glargine,hum.Rec.Anlog11$1,388
Nebivolol Hcl20$1,220
Cyclobenzaprine Hcl14$1,089

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$34$74,14557 claims
Novo NordiskOzempic$81$58,97447 claims
PfizerEliquis$52$31,75439 claims
Boehringer IngelheimJardiance$13$19,22817 claims
MerckJanuvia$40$15,44715 claims
GSKTrelegy Ellipta$20$14,53923 claims
AstraZenecaFarxiga$239$12,51018 claims
Johnson & JohnsonXarelto$34$10,90312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Mount Vernon

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →